A Prospective Study on the Factors Sustaining Tobacco Abstinence in Patients Treated With Radio-chemotherapy or Radiotherapy Alone for Head and Neck or Lung Cancer (TABAC STOP ORL)

NCT06910566 ACTIVE_NOT_RECRUITING

The TABAC STOP ORL POUMON study aims to evaluate the factors influencing long-term smoking cessation in patients with head and neck cancer (HNC) or lung cancer undergoing radiotherapy or chemoradiotherapy. This is a single-center observational study, following patients at 1, 6, and 12 months after treatment completion. The primary objective is to determine the proportion of abstinent patients at 6 months, while secondary objectives analyze factors influencing abstinence, smoking trajectories, and reasons for relapse. A total of 100 patients will be included to ensure robust statistical analysis.

Details

Lead sponsor	Centre Oscar Lambret
Status	ACTIVE_NOT_RECRUITING
Enrolment	100
Start date	2022-03-28
Completion	2026-11

Conditions

• Smoking Cessation
• Nicotine Addiction
• Nicotine Dependence
• Smoking
• Head and Neck Neoplasms

Interventions

• Chemoradiotherapy or radiotherapy alone

Primary outcomes

• Abstinence at 1 month and 6 months after the end of treatment — 1 and 6 months after the end of treatment.
  The primary outcome measure will be abstinence at 1 month (physical consultation or telephone follow-up) and at 6 months after the end of treatment.

Countries

France